Association of pre-hospital theophylline use and mortality in chronic obstructive pulmonary disease patients with sepsis
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference40 articles.
1. The third international consensus definitions for sepsis and septic shock (Sepsis-3);Singer;Jama,2016
2. Benchmarking the incidence and mortality of severe sepsis in the United States;Gaieski;Crit. care Med.,2013
3. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care;Angus;Crit. care Med.,2001
4. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007;Lagu;Crit. care Med.,2012
5. Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006;Shen;Chest,2010
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A narrative review of theophylline: is there still a place for an old friend?;Journal of Thoracic Disease;2024-05
2. Use of Peak Glucose Level and Peak Glycemic Gap in Mortality Risk Stratification in Critically Ill Patients with Sepsis and Prior Diabetes Mellitus of Different Body Mass Indexes;Nutrients;2023-09-14
3. Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-07-19
4. Theophylline attenuates bleomycin-induced oxidative stress in rats: The role of IL-6, NF-κB, and antioxidant enzymes;Brazilian Journal of Pharmaceutical Sciences;2022
5. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2019-11
Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3